Allergy and Immunotherapy During the Pandemic.
Elizabeth Mahoney DavisPublished in: Current otorhinolaryngology reports (2022)
Resuming outpatient allergy services in the setting of the COVID-19 pandemic poses many challenges to the practitioner. Allergy specialists are now faced with developing prudent and evidence-based strategies for safely resuming allergen immunotherapy, while also maintaining a safe environment for staff and patients.